K-numberK251570
Device nameHippocampe Marathon and Trail
ApplicantVipamat Sarl
Product codeIQC
Device classClass II
Decision dateJun 23, 2025
DecisionSubstantially Equivalent
Regulation890.3880
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The Hippocampe Marathon and Trail is a three-wheeled manual wheelchair designed to provide mobility to persons restricted to a seated position on various terrains, including footpaths and trails, both indoors and outdoors. It features a bent aluminum frame with adjustable seat height and headrest, disc brakes operable by a care provider, and a maximum weight capacity of 220 lbs. The device is available in three sizes and can be disassembled for storage.

Technological characteristics

Both the subject and predicate devices share a three-wheel frame design with detachable armrests, adjustable headrests, and height-adjustable backrests. The subject device has a lower weight capacity (220 lbs vs. 286 lbs) and features operational disc brakes for motion control in addition to parking brakes, whereas the predicate has only parking brakes. The subject device uses rigid-frame seating upholstery compared to the predicate's sling-style, and offers optional trail wheels similar to the predicate's standard wheels.

Test standards cited

ISO 7176-1 (static stability), ISO 7176-3 (brake effectiveness), ISO 7176-5 (dimensions and maneuvering space), ISO 7176-7 (seating and wheel dimensions), ISO 7176-8 (static/impact/fatigue strength), ISO 7176-11 (test dummies), ISO 7176-13 (friction), ISO 7176-15 (labeling and documentation), NF ISO 7176-16 (ignition resistance), and NF ISO 7176-22 (setup procedures).

Substantial equivalence argument

The subject device shares the same fundamental three-wheel mechanical design, materials (aluminum tubing), and intended use as the predicate device. Although the subject has a lower weight capacity (220 vs. 286 lbs) and more limited terrain scope (footpaths and trails versus sand/snow/water), these differences do not raise safety or performance concerns because the reduced capacity is properly labeled and the narrower terrain indication represents a subset of uses rather than a fundamentally different design. Both devices passed the same ISO performance standards for stability, braking, and structural strength, demonstrating substantial equivalence in safety and effectiveness.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →